WASHINGTON, D.C.: United States biotechnology firm Moderna said Tuesday (Wednesday in Manila) it would enter the final stage of human trials for its coronavirus disease 2019 (Covid-19) vaccine on July 27, to test how well it protects people in the real world.
BOOST FOR CURE In this March 16, 2020 file photo, a subject gets a shot in the first stage safety study clinical trial of Moderna, a potential vaccine against Covid-19, at the Kaiser Permanente Washington Health Research Institure in Seattle. Results released on July 14, 2020 showed that the vaccine by the National Institutes of Health and Moderna Inc. boosted people’s immune systems. AP PHOTO